Učitavanje...

Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma

The combination of clarithromycin, lenalidomide and dexamethasone (BiRd) has led to highly durable responses in newly diagnosed myeloma. However, the ability of clarithromycin to overcome resistance to lenalidomide and dexamethasone (Rd) is not known. To study this, we performed a retrospective anal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Hematol
Glavni autori: Ghosh, Nilanjan, Tucker, Noah, Zahurak, Marianna, Wozney, Jocelyn, Borrello, Ivan, Huff, Carol Ann
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4390045/
https://ncbi.nlm.nih.gov/pubmed/24723438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23733
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!